These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16492805)

  • 1. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.
    Pasqualucci L; Compagno M; Houldsworth J; Monti S; Grunn A; Nandula SV; Aster JC; Murty VV; Shipp MA; Dalla-Favera R
    J Exp Med; 2006 Feb; 203(2):311-7. PubMed ID: 16492805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel BLIMP1/PRDM1 gene mutations in B-cell lymphoma.
    Tate G; Hirayama-Ohashi Y; Kishimoto K; Mitsuya T
    Cancer Genet Cytogenet; 2007 Jan; 172(2):151-3. PubMed ID: 17213024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas.
    Boi M; Zucca E; Inghirami G; Bertoni F
    Leuk Lymphoma; 2015 May; 56(5):1223-8. PubMed ID: 25115512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
    Tam W; Gomez M; Chadburn A; Lee JW; Chan WC; Knowles DM
    Blood; 2006 May; 107(10):4090-100. PubMed ID: 16424392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma.
    Mandelbaum J; Bhagat G; Tang H; Mo T; Brahmachary M; Shen Q; Chadburn A; Rajewsky K; Tarakhovsky A; Pasqualucci L; Dalla-Favera R
    Cancer Cell; 2010 Dec; 18(6):568-79. PubMed ID: 21156281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.
    Wilkinson ST; Vanpatten KA; Fernandez DR; Brunhoeber P; Garsha KE; Glinsmann-Gibson BJ; Grogan TM; Teruya-Feldstein J; Rimsza LM
    Blood; 2012 Feb; 119(6):1459-67. PubMed ID: 22167754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL.
    Cubedo E; Maurin M; Jiang X; Lossos IS; Wright KL
    FEBS J; 2011 Sep; 278(17):3065-75. PubMed ID: 21722313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
    [No Abstract]   [Full Text] [Related]  

  • 9. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10.
    Mock BA; Liu L; LePaslier D; Huang S
    Genomics; 1996 Oct; 37(1):24-8. PubMed ID: 8921366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
    Xia Y; Xu-Monette ZY; Tzankov A; Li X; Manyam GC; Murty V; Bhagat G; Zhang S; Pasqualucci L; Visco C; Dybkaer K; Chiu A; Orazi A; Zu Y; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Westin J; Fowler N; Miranda RN; Ok CY; Li Y; Li J; Medeiros LJ; Young KH
    Leukemia; 2017 Mar; 31(3):625-636. PubMed ID: 27568520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
    Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
    Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.
    Valera A; Colomo L; Martínez A; de Jong D; Balagué O; Matheu G; Martínez M; Taddesse-Heath L; Jaffe ES; Bacchi CE; Campo E
    Mod Pathol; 2013 Oct; 26(10):1329-37. PubMed ID: 23599149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blimp-1 is a tumor suppressor gene in lymphoid malignancies.
    Hangaishi A; Kurokawa M
    Int J Hematol; 2010 Jan; 91(1):46-53. PubMed ID: 20047096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma.
    Courts C; Montesinos-Rongen M; Brunn A; Bug S; Siemer D; Hans V; Blümcke I; Klapper W; Schaller C; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2008 Jul; 67(7):720-7. PubMed ID: 18596541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
    Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
    Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas.
    Vrzalikova K; Woodman CB; Murray PG
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):1-6. PubMed ID: 22580854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
    Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
    J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.